Contents
Biktarvy Generic
Pronunciation: (bik-TAR-vee)
Biktarvy generic, Biktarvy and bictegravir, emtricitabine & tenofovir alafenamide will be used interchangeably in this article.
Biktarvy generic is an oral tablet, bictegravir 50 mg, emtricitabine 200 mg and tenofovir alafenamide 25 mg, taken daily with or without food for adults.
Children taking Biktarvy should be atleast 31 lbs. or 14 kg.
Other HIV 1 treatments should not be taken with Biktarvy.
Bictegravir, emtricitabine and tenofovir alafenamide or Biktarvy generic is a prescription medicine to treat HIV 1.
This drug does not prevent HIV, it can reduce the viral load of the HIV virus that causes AIDS.
Biktarvy generic is not available in the US, but it can be imported.
Outside of the US, Biktarvy generic is accessible and affordable.
Read about Biktarvy generic in the National Institute of Health article.
Hey Kris, thanks for letting me order another year’s worth of Biktarvy for my friend. I know you don’t want people reselling Biktarvy.
– Dale Lennard
Tucson, Arizona
The molecular composition is the same; bictegravir, emtricitabine and tenofovir alafenamide.
Biktarvy is not used for HIV prevention like PrEP (Truvada & Descovy), it is also not a cure for AIDS.
Bictegravir, emtricitabine and tenofovir alafenamide is an antiretroviral treatment developed and manufactured by Gilead Sciences in 2018 for HIV 1 infections. This medicine was approved by the FDA in February 2018.
Emtricitabine and tenofovir alafenamide were previously approved by the FDA.
Bictegravir is a new drug for HIV 1 treatment and is now been approved.
WARNING: Biktarvy can reactivate hepatitis B infections. Consult with your doctor and get tested for HBV prior to starting treatment.
Who can take Biktarvy generic?
If you have kidney or liver disease, you should not take Biktarvy.
Patients with HIV 1 RNA that are 50 ml and less can take bictegravir, emtricitabine and tenofovir alafenamide (Biktarvy generic).
Patients that are resistant to bictegravir, emtricitabine and tenofovir alafenamide or experienced failure with this treatment, should not take Biktarvy.
Generally, patients that have not been treated with antiretroviral treatment can take bictegravir, emtricitabine and tenofovir alafenamide, Biktarvy.
What is HIV?
HIV or human immunodeficiency virus that attacks the body’s immune system.
So, your body’s natural immunity is reduced and weakened, allowing for infections to take hold in the body.
Once HIV compromises your immunity, you develop AIDS.
AIDS is an acronym for acquired immunodeficiency syndrome that results from untreated HIV.
Prevention of AIDS is possible with antiretroviral treatment for HIV 1, with bictegravir, emtricitabine and tenofovir alafenamide, Biktarvy.
How effective is Biktarvy generic (bictegravir, emtricitabine and tenofovir alafenamide)?
Over the years several studies have been conducted around the globe on the efficacy of Biktarvy generic.
The most famous of these studies showed HIV 1 RNA virus level 50 copies/ml in a one year period.
Usually, it takes about 8 weeks to 24 weeks for the viral load to become undetectable.
Most HIV patients can take bictegravir, emtricitabine and tenofovir alafenamide this medicine.
HLA-B5701 carriers of the gene can take Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide).
Generic Biktarvy does not contain abacavir, which is present in Trizivir and Triumeq, which can be fatal to patients that carry HLA-B5701 gene variant.
Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) Side Effects:
The most common side effects of Biktarvy include:
- Nausea
- Diarrhea
- Headache
Less common side effects of Biktarvy include:
- Lactic acidosis (build-up of lactic acid in the blood)
- Liver damage
- Allergic reactions
It’s important to note that this list is not exhaustive and that other side effects may occur. If you experience any unusual symptoms while taking Biktarvy, it’s important to report them to your healthcare provider. They can assess whether the symptoms are related to the medication and advise you on how to manage them.
A rare side effect of Biktarvy is lactic acidosis, which is a build-up of lactic acid in the blood.
Lactic acidosis can cause symptoms such as stomach pain, muscle cramps, weakness, difficulty breathing, dizziness, and fatigue.
It is a rare but serious condition that can be life-threatening if left untreated.
Another rare side effect of Biktarvy is liver damage.
This can cause symptoms such as yellowing of the skin and whites of the eyes, dark urine, and abdominal pain.
People who have liver problems or who drink large amounts of alcohol may be more at risk for this side effect.
In addition to lactic acidosis and liver damage, Biktarvy can also cause other side effects such as nausea, diarrhea, and headache.
These side effects are typically mild and may go away on their own over time.
Biktarvy is generally well-tolerated and effective at treating HIV-1 infection.
It is important for people who are taking Biktarvy to report any side effects to their healthcare provider so that they can be monitored and treated if necessary.
Overall, it is important to weigh the potential risks and benefits of any medication before starting treatment.
While Biktarvy may cause side effects in some people, it can also greatly improve the quality of life and long-term health outcomes for those living with HIV-1 infection.